Hangzhou Tigermed Consulting

Hangzhou Tigermed Consulting

World Rank (Jan-05-2024)
2,560
Market Cap (Jan-05-2024)
5.923 Billion USD
World Rank (Jul-30-2023)
2,038
Market Cap (Jul-30-2023)
7.853 Billion USD
World Rank (Jan-07-2022)
1,403
Market Cap (Jan-07-2022)
14.371 Billion USD
World Rank (Jan-01-2021)
864
Market Cap (Jan-01-2021)
21.361 Billion USD
Company Rank in Country in 2023
Rank in China in July-2023 is 289
Headquarters Country
China
Market Cap (Mar-08-2026)
7.41
Employee Count
9,233
Employee Count as of Date
As on 2022
Headquarters City/State
Hangzhou
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
993 Million USD
Annual Operating Income in USD
254 Million USD
Annual Net Income in USD
281 Million USD
Annual Results for Period Ending
Dec-2022 ending period
Total Assets in USD
3,847 Million USD
Total Liabilities in USD
668 Million USD
Total Equity in USD
3,179 Million USD
Balance Sheet for Period Ending
Dec-2022 ending period
Business Sector
Healthcare
Health Care Diagnostics
Company Website
HANGZHOU TIGERMED CONSULTING
Yahoo
Yahoo @ Shenzhen
Company Profile

Provides clinical research information to the pharmaceutical companies. Headquarters is in China.

They are leading clinical Contract Research Organization (CRO) in China, they are dedicated to provide services for new drug research and development and other supporting services to global and Chinese pharmaceutical and biotechnology companies.

Founded Year
2004
Stock Exchange
Shenzhen
Company SubCategory
Top Healthcare Companies in China

Share